My NCBI | Sign In
RSS Settings
  • Search: Hale PM[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 22

    1.

    Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

    Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L; LEAD-4 Study Investigators.

    Diabetes Care. 2009 Jul;32(7):1224-30. Epub 2009 Mar 16.PMID: 19289857 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B; LEAD-3 (Mono) Study Group.

    Lancet. 2009 Feb 7;373(9662):473-81. Epub 2008 Sep 24.PMID: 18819705 [PubMed - indexed for MEDLINE]Related articles

    3.

    Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.

    Rosenstock J, Hassman DR, Madder RD, Brazinsky SA, Farrell J, Khutoryansky N, Hale PM; Repaglinide Versus Nateglinide Comparison Study Group.

    Diabetes Care. 2004 Jun;27(6):1265-70.PMID: 15161773 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone.

    Raskin P, McGill J, Saad MF, Cappleman JM, Kaye W, Khutoryansky N, Hale PM; Repaglinide/Rosiglitazone Study Group.

    Diabet Med. 2004 Apr;21(4):329-35.PMID: 15049934 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.

    Jovanovic L, Hassman DR, Gooch B, Jain R, Greco S, Khutoryansky N, Hale PM.

    Diabetes Res Clin Pract. 2004 Feb;63(2):127-34.PMID: 14739053 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

    Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM; Repaglinide vs. Nateglinide Metformin Combination Study Group.

    Diabetes Care. 2003 Jul;26(7):2063-8. Erratum in: Diabetes Care. 2003 Sep;26(9):2708. PMID: 12832314 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Assessment of growth and immunologic function in HIV-infected and exposed children.

    Lipman TH, Deatrick JA, Treston CS, Lischner HW, Logan J, Hassey K, Hale PM, Singer-Granick C.

    J Assoc Nurses AIDS Care. 2002 May-Jun;13(3):37-45.PMID: 12064020 [PubMed - indexed for MEDLINE]Related articles

    8.

    Assessment of growth by primary health care providers.

    Lipman TH, Hench K, Logan JD, DiFazio DA, Hale PM, Singer-Granick C.

    J Pediatr Health Care. 2000 Jul-Aug;14(4):166-71.PMID: 10900413 [PubMed - indexed for MEDLINE]Related articles

    9.

    Risk factors for cardiovascular disease in children with Type I diabetes.

    Lipman TH, Hayman LL, Fabian CV, DiFazio DA, Hale PM, Goldsmith BM, Piascik PC.

    Nurs Res. 2000 May-Jun;49(3):160-6.PMID: 10882321 [PubMed - indexed for MEDLINE]Related articles

    10.

    Factors predicting cerebral edema in young children with diabetic ketoacidosis and new onset type I diabetes.

    Hale PM, Rezvani I, Braunstein AW, Lipman TH, Martinez N, Garibaldi L.

    Acta Paediatr. 1997 Jun;86(6):626-31.PMID: 9202799 [PubMed - indexed for MEDLINE]Related articles

    11.

    Improvement of cortical morphology in infantile hydrocephalic animals after ventriculoperitoneal shunt placement.

    Hale PM, McAllister JP 2nd, Katz SD, Wright LC, Lovely TJ, Miller DW, Wolfson BJ, Salotto AG, Shroff DV.

    Neurosurgery. 1992 Dec;31(6):1085-96; discussion 1096.PMID: 1470319 [PubMed - indexed for MEDLINE]Related articles

    12.

    Diagnosis and treatment of thyroid disease in infants.

    Postellon DC, Hale PM.

    Compr Ther. 1991 Jul;17(7):57-61. Review. No abstract available. PMID: 1742971 [PubMed - indexed for MEDLINE]Related articles

    13.

    Testosterone infusion reduces nocturnal luteinizing hormone pulse frequency in pubertal boys.

    Foster CM, Hassing JM, Mendes TM, Hale PM, Padmanabhan V, Hopwood NJ, Beitins IZ, Marshall JC, Kelch RP.

    J Clin Endocrinol Metab. 1989 Dec;69(6):1213-20.PMID: 2685008 [PubMed - indexed for MEDLINE]Related articles

    14.

    Tactical considerations for HIS strategy--Part II.

    Hale PM.

    Comput Healthc. 1989 Nov;10(11):44, 47, 49.PMID: 10304093 [PubMed - indexed for MEDLINE]Related articles

    15.

    Nocturnal serum growth hormone concentration is not augmented by short-term testosterone infusion in pubertal boys.

    Foster CM, Hopwood NJ, Hassing JM, Hale PM, Mendes T, Kelch RP, Beitins IZ.

    Pediatr Res. 1989 Oct;26(4):320-4.PMID: 2797945 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tactical considerations for HIS strategy--Part I.

    Hale PM.

    Comput Healthc. 1989 Oct;10(10):39-40. No abstract available. PMID: 10295453 [PubMed - indexed for MEDLINE]Related articles

    17.

    T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction.

    Hale PM, Cease KB, Houghten RA, Ouyang C, Putney S, Javaherian K, Margalit H, Cornette JL, Spouge JL, DeLisi C, et al.

    Int Immunol. 1989;1(4):409-15.PMID: 2484961 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of human growth hormone on insulin-stimulated glucose metabolism in 3T3-F442A adipocytes.

    Foster CM, Hale PM, Jing HW, Schwartz J.

    Endocrinology. 1988 Aug;123(2):1082-8.PMID: 3293980 [PubMed - indexed for MEDLINE]Related articles

    19.

    The single-vendor path to the future.

    Hale PM.

    Healthc Comput Commun. 1988 Jul;5(7):58-60. No abstract available. PMID: 10287795 [PubMed - indexed for MEDLINE]Related articles

    20.

    Increased luteinizing hormone pulse frequency during sleep in early to midpubertal boys: effects of testosterone infusion.

    Hale PM, Khoury S, Foster CM, Beitins IZ, Hopwood NJ, Marshall JC, Kelch RP.

    J Clin Endocrinol Metab. 1988 Apr;66(4):785-91.PMID: 3346356 [PubMed - indexed for MEDLINE]Related articles

    21.

    State of the art: islet cell antibody tests.

    Hale PM, Pasquarello TJ, Vardi P.

    Diabetes Educ. 1987 Fall;13(4):381-5. No abstract available. PMID: 3311673 [PubMed - indexed for MEDLINE]Related articles

    22.

    Monoclonal antibodies against ovalbumin.

    Bjercke RJ, Hale PM, Mercer WD, McGuire WL.

    Biochem Biophys Res Commun. 1981 Mar 31;99(2):550-6. No abstract available. PMID: 7236283 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity